GlassScriptPhysician profile
Kelly Mcdowell
NPI 1174877195
$9,440.64
in general payments reported to CMS, 2019-2025
38 companies · $715 in 2025
The $715 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,297 · 2022: $2,491 · 2023: $2,050 · 2024: $1,888 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,653.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,171.92 | 2021-2024 | Senza |
| Si-Bone, INC. | $1,550.99 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $889.48 | 2021-2025 | Xtampza, Belbuca |
| Boston Scientific Corporation | $632.79 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $553.90 | 2024-2025 | Prospera |
| Forte Bio-Pharma LLC | $300.65 | 2022-2024 | Prolate, Nalocet |
| Stimwave Technologies Incorporated | $290.78 | 2021-2022 | |
| Abbott Laboratories | $260.85 | 2021-2025 | Eterna, Proclaim |
| Relievant Medsystems, INC. | $212.80 | 2022-2023 | Intracept |
| Amgen INC. | $183.05 | 2021 | |
| Medtronic, INC. | $130.52 | 2022 | |
| Grt US Holding, INC. | $118.69 | 2021-2022 | |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.36 | 2022-2024 | Relistor |
| Scilex Pharmaceuticals INC. | $87.66 | 2022-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.